ArticleThe Lancet. Oncology2026

Deep learning on histopathological images to predict breast cancer recurrence risk and chemotherapy benefit: a multicentre, model development and validation study.

Gil Shamai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.